Is interleukin-2 therapy still a risk factor for adverse reactions in concert with iodinated contrast medium injection?

Acta Radiologica

Volumn 50, Issue 7, 2009, Pages 752-753

  Boehm, I ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; INTERLEUKIN 2; IODINE;

DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; HUMAN; LETTER; RISK FACTOR;

CONTRAST MEDIA; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-2; IODINE; RISK FACTORS;

EID: 69949144221     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850903061452     Document Type: Letter

References (12)

1. Cochran ST. Anaphylactoid reactions to radiocontrast media. Curr Allergy Asthma Report 2005;5:28-31.
2. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621-8.
3. Boehm I. Contrast medium and patients at risk: asthma. Acta Radiol 2009;50:348.
4. Morcos SK, Bellin MF, Thomsen HS, Almen T, Aspelin P, Heinz-Peer G, et al. Contrast Media Safety Committee of European Society of Urogenital Radiology. Reducing the risk of iodine-based and MRI contrast media administration: recommendation for a questionnaire at the time of booking. Eur J Radiol 2008;66: 225-9.
5. Brockow K, Christiansen C, Kanny G, Clement O, Barbaud A, Bircher A, et al. EAACI interest group on drug hypersensitivity. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005;60: 150-8.
6. Liccardi G, Lobefalo G, Di Florio E, Di Iorio C, Occhiochiuso L, Romano L, et al. Cardarelli Hospital Radiocontrast Media and Anesthetic-Induced Anaphy-laxis Prevention Working Group. Strategies for the prevention of asthmatic, anaphylactic and anaphylac-toid reactions during the administration of anesthetics and/or contrast media. J Investig Allergol Clin Immunol 2008;18:1-11.
7. Zukiwski AA, David CL, Coan J, Wallace S, Gutterman JU, Mavligit GM. Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration. Cancer 1990;65: 1521-4.
8. Oldham RK, Brogley J, Braud E. Contrast medium "recalls" interleukin-2 toxicity. J Clin Oncol 1990;8: 942-3.
9. Carrington BM, Thomas NB, Johnson RJ. Selective splenic arteriography for interleukin-2 administration: radiologic complications from the initial 113 procedures. Eur J Radiol 1992;14:13-7.
10. Abi-Aad AS, Figlin RA, Belldegrun A, de Kernion JB. Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection. J Immunother 1991; 10:292-5.
11. Choyke PL, Miller DL, Lotze MT, Whiteis JM, Ebbitt B, Rosenberg SA. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 1992;183: 111-4.
12. Schild HH, Kuhl CK, Hubner-Steiner U, Bohm I, Speck U. Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. Radiology 2006;240:56-64.